Location History:
- Rostock, DE (2005)
- Weinheim, DE (2006)
Company Filing History:
Years Active: 2005-2006
Title: Matthias Löhr: Innovator in Medical Technology
Introduction
Matthias Löhr is a notable inventor based in Weinheim, Germany. He has made significant contributions to the field of medical technology, particularly in the development of innovative injection devices and diagnostic methods for pancreatic cancer. With a total of 3 patents to his name, Löhr's work exemplifies the intersection of engineering and healthcare.
Latest Patents
One of Löhr's latest patents is an injection device and method for injecting capsules. This invention features a hollow needle and a cutting needle that can be inserted into the hollow needle, which has a cutting tip projecting from its front end. The device includes a catheter that can replace the cutting needle and is designed to deliver capsules to a target area of the body without exerting pressure. The capsules are released once the injection device is properly positioned, allowing for a more efficient and less invasive method of delivery. Another significant patent involves the use of MUCIN 4 expression as a marker for pancreatic cancer, providing methods for the diagnosis of this serious condition.
Career Highlights
Throughout his career, Matthias Löhr has worked with several prominent organizations, including Bavarian Nordic A/S and the University of Nebraska. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in medical technology.
Collaborations
Löhr has collaborated with notable professionals in his field, including Walter Henry Günzburg and Surinder K Batra. These partnerships have further enhanced his research and development efforts, leading to innovative solutions in healthcare.
Conclusion
Matthias Löhr's contributions to medical technology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the way medical procedures are performed, particularly in the diagnosis and treatment of pancreatic cancer.